JOIN DSMIG TODAY


Statement from Roche on Phase II CLEMATIS Trial

28 Jun 2016 5:15 PM | Anonymous member (Administrator)

 This phase II study did not meet its primary and secondary endpoints on improvement in cognition and function

Roche statement: http://www.roche.com/media/store/statements.htm

LuMind statement1: https://www.lumindrds.org/response-on-the-roche-clinical-trial-for-clematis/

LuMind statement2: https://www.lumindrds.org/statement-from-lumind-research-down-syndrome-foundation-on-the-roche-clinical-trials/



Down Syndrome Medical Interest Group-USA

DSMIG-USA is a 501(3)(c) Organization

Contact Us

Site Design by:  Site to be Seen


Powered by Wild Apricot Membership Software